Meftal%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520spas

# Meftal spas ## Overview Meftal spas is a combination product containing mefenamic acid (a nonsteroidal anti-inflammatory drug, NSAID) and hyoscine butylbromide (an antispasmodic). Mefenamic acid reduces inflammation and pain, while hyoscine butylbromide relaxes smooth muscle in the gastrointestinal tract. ## Primary Indications * Symptomatic relief of abdominal pain associated with muscle spasms, particularly in conditions like irritable bowel syndrome, diverticulitis, and spastic colitis. * Management of dysmenorrhea. ## Adult Dosing * **Mefenamic Acid Component:** Typically 500 mg every 8 hours. * **Hyoscine Butylbromide Component:** Typically 10 mg every 8 hours. * **Combined Product:** Follow the specific dosing instructions on the product packaging. A common adult dose is one tablet (containing both active ingredients) every 8 hours as needed for pain and spasms. The maximum daily dose for mefenamic acid is generally 1500 mg. ## Pediatric Dosing Pediatric dosing for this specific combination product is not well-established. Mefenamic acid alone can be dosed in children 6 months and older, but hyoscine butylbromide is generally not recommended for children under 12 years of age due to potential anticholinergic side effects. **Consult current pediatric guidelines or a pediatrician for appropriate treatment options in children.** ## Dose Adjustments * **Renal Impairment:** Mefenamic acid should be used with caution in patients with impaired renal function. Dose reduction may be necessary, or alternative analgesics/antispasmodics should be considered. * **Hepatic Impairment:** Mefenamic acid should be used with caution in patients with impaired hepatic function. * **Elderly:** Elderly patients may be more susceptible to NSAID-related adverse effects, particularly gastrointestinal bleeding and renal toxicity. Use with caution and the lowest effective dose. ## Contraindications * Hypersensitivity to mefenamic acid, hyoscine butylbromide, or any component of the formulation. * History of bronchospasm, urticaria, or allergic-type reactions after aspirin or other NSAIDs. * Severe renal impairment. * Severe hepatic impairment. * Glaucoma (especially narrow-angle glaucoma). * Myasthenia gravis. * Tachycardia. * Ileus or paralytic ileus. * Prostatic hypertrophy with urinary retention. * Pyloric stenosis or megacolon. * Patients with a history of gastrointestinal bleeding or perforation related to NSAID therapy. ## Adverse Effects * **Common (Mefenamic Acid):** Nausea, vomiting, diarrhea, abdominal pain, dyspepsia, headache, dizziness. * **Less Common (Mefenamic Acid):** Gastrointestinal bleeding, ulceration, perforation, renal impairment, hypersensitivity reactions (rash, asthma), confusion, drowsiness. * **Common (Hyoscine Butylbromide):** Dry mouth, blurred vision, constipation, difficulty urinating, tachycardia. * **Less Common (Hyoscine Butylbromide):** Drowsiness, confusion, dizziness, skin rash. ## Key Drug Interactions * **NSAIDs:** Increased risk of gastrointestinal bleeding and renal toxicity when used concurrently with other NSAIDs, including aspirin. * **Anticoagulants (e.g., Warfarin):** Increased risk of bleeding. * **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding. * **Diuretics and Antihypertensives:** NSAIDs can reduce the efficacy of these drugs and increase the risk of renal impairment. * **Lithium:** NSAIDs can increase lithium levels. * **Methotrexate:** NSAIDs can increase methotrexate toxicity. * **Anticholinergics:** Additive anticholinergic effects when combined with hyoscine butylbromide. * **Dopamine Antagonists (e.g., Metoclopramide):** May reduce the efficacy of hyoscine butylbromide. ## Monitoring * **Renal function:** Monitor serum creatinine and BUN, especially in patients with pre-existing renal disease or those at risk. * **Hepatic function:** Monitor liver enzymes, especially in patients with liver disease. * **Gastrointestinal symptoms:** Assess for signs of bleeding or ulceration (e.g., melena, hematemesis, abdominal pain). * **Blood pressure:** Monitor blood pressure, as NSAIDs can cause fluid retention and hypertension. * **Signs of anticholinergic effects:** Monitor for dry mouth, blurred vision, urinary retention, and constipation, especially in the elderly. ## Clinical Pearls * Administer with food or milk to minimize gastrointestinal upset. * Use the lowest effective dose for the shortest duration necessary to minimize risks. * Be aware of the potential for serious gastrointestinal events, even without prior history. * Consider alternative pain management strategies for patients with cardiovascular risk factors, renal impairment, or a history of peptic ulcer disease. * Inform patients about potential side effects and when to seek medical attention. *** **Disclaimer:** This information is intended for healthcare professionals. It is crucial to consult the most current prescribing information and relevant clinical guidelines for definitive guidance. Dosing and safety can vary based on individual patient factors and local protocols.